|
|
As Population Ages And Need For Palliative Care Grows, Experts Tackle New Challenge For The First Time At European Meeting |
How Cephalexin care of us.Cephalexin: uses Cephalexin is a cephalosporin-type antibiotic used to treat a wide variety of bacterial infections ( e. g. , skin, bone and genitourinary tract infections ) . It works by stopping growth of bacteria. Cephalexin: how to use Take Cephalexin by mouth usually every 6 or 12 hours, or as directed by your doctor. You may take this medicine with food if stomach upset occurs. Cephalexin: other used This section contains uses of Cephalexin that aren't listed in approved professional labeling for drug but that may be prescribed by your health care professional. Use Cephalexin for a condition that's listed in this section only if it has been so prescribed by your health care professional. Cephalexin: side effects Stomach upset, headache, fatigue, dizziness, or diarrhea may occur while use Cephalexin. If any of these effects persist or worsen, notify your doctor or pharmacist promptly. Cephalexin: precautions Before taking Cephalexin, tell your doctor or pharmacist if we are allergic to it; or to penicillins or other cephalosporins; or if we have any other allergies. Cephalexin: interactions Your healthcare professionals ( e. g. , doctor or pharmacist ) may already be aware of any possible drug interactions and may be monitoring you for it. Do not start, stop or change dosage of any medicine before checking with them first. Cephalexin with EU shipping |
As Population Ages And Need For Palliative Care Grows, Experts Tackle New Challenge For The First Time At European Meeting Experts from across Europe are gathering at a scientific symposium held at fifth European Association for Palliative Care ( EAPC ) congress in Trondheim, Norway, on 29th May, to discuss the challenges of managing an overlooked and distressing symptom that affects large numbers of patients receiving opioids as part of palliative care management for advanced illness: opioid-induced constipation ( OIC ) . It's a condition that is often under-diagnosed in patients in the palliative care setting. As Europe's population ages, so number of patients living with advanced illness is likely to increase. 1 Pain relief is often a key part of palliative care and opioids are routinely used to relieve the pain. 2 However, effective pain relief provided by opioids is often accompanied with a less welcome side-effect and OIC is a near universal occurrence in patients receiving opioid analgesics in palliative care setting. 3, 4 OIC can be so severe, that it may result in patients choosing to sacrifice their pain medication, to mitigate the problem. " OIC usually goes under-diagnosed', says Professor Kaasa, St Olave's University Hospital, Norway. " Clinicians do not ask about it and patients do not talk about it, which means it's often poorly managed. The discomfort and distress of OIC can affect the quality of life of patients receiving palliative care for advanced illness. " " OIC is a significant cause of distress', concurs Dr Philip Larkin, Senior Lecturer in Nursing, National University of Ireland. " A recent survey showed that a third of patients in Europe with moderate to severe symptoms receive no treatment. 5 We need to put in place a European-wide consensus on how to diagnose and manage this problem now, as demand for palliative care is growing and is predicted to continue to grow as the population of Europe ages. " " For too long OIC has been a burden for our patients despite our current treatments', notes Dr Jay Thomas, Center for Palliative Studies at San Diego Hospice and The Institute for Palliative Medicine, United States. " As clinicians, we've to be vigilant to diagnose it and aggressively treat it. Having new tools that enable OIC to be treated without interfering with pain management is a welcome addition that can help relieve suffering and give patients back some control and quality of life. " Each year, more than 1. 5 million Americans receive palliative care due to an advanced illness, such as incurable cancer, end-stage heart and lung disease, or AIDS. 6, 7 Similar figures are not available for Europe, which may be considered indicative of fact that this is an overlooked condition and an area of unmet medical need. However, despite this problem and the limitations of laxative therapies experts concluded that with introduction of novel targeted therapies, outlook for patients suffering from distressing condition looks more positive. The clinical impact of OIC was discussed at a scientific symposium sponsored by Wyeth, which convened a wide range of experts in palliative care including geriatricians, oncologists, nurses, researchers, palliative care physicians and general physicians. The experts will discuss challenges in diagnosing and managing the condition in patients in palliative care setting. They will also be discussing the limitations of laxative therapies and insights into future with novel targeted therapies which convey a bright outlook for the distressing condition. About Wyeth Pharmaceuticals Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, oncology, vaccines and nutritional products. Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products, nutritionals and non-prescription medicines that improve quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health. Additional information on Wyeth is available at http: //www. wyeth. eu The EAPC Research Forum addresses researchers and clinicians from all disciplines specialised in palliative care. Wyeth is developing methylnaltrexone bromide, a peripherally acting mu-opioid receptor antagonists ( PAMORA ) that reverses constipating effects of opioid pain medications in gastrointestinal tract without affecting their ability to relieve pain. In April 2008 it was approved for use in the US by Food and Drug Administration and received a positive opinion from Committee for Medicinal Products for Human Use ( CHMP ) in Europe. References 1. Davies E, Higginson I. Better Palliative Care for Older People. WHO, 2004. See here. 2. Gutstein HB, Akil H. Opioid Analgesics. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th Ed. New York, NY: McGraw-Hill; 2006: 547-590 3. Fallon MT. Constipation in cancer patients: prevalence, pathogenesis, and cost-related issues. Eur J Pain. 1999; 3 ( suppl A ) : 3-7 4. Emanuel EJ, Emanuel LL. Palliative and end-of-life care. In: Kasper DL, Braunwald E, Fauci AS, et al, eds. Harrison's Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005: 53-66 5. Laugsand EA, EAPC et al. Unpublished findings 6. Miniño AM, Heron M, Murphy SL, et al. Deaths: final data for 2004. Health E-Stats. Released November 24, 2006. Available here. Accessed March 9, 2007 7. National Hospice and Palliative Care Organization. NHPCO's Facts and Figures - 2005 Findings. Available here. Accessed May 30, 2007 Wyeth Pharmaceuticals Your health in your hand. Your choice - follow advice or no. |
Warning Required for Nonoxynol 9 Over-the-Counter Contraceptives. Over-the-counter, stand-alone vaginal contraceptive and spermicidal products containing the chemical ingredient nonoxynol 9 (N9) must now include a warning that the chemical does not protect against infection from HIV or other sexually transmitted diseases "My Medicines" This Brochure Can be a Lifesaver. "My Medicines," a brochure offered by FDA's Office of Women's Health, can play a vital role in the medical treatment you receive during an emergency. First Quick Test for Deadly, Drug-Resistant MRSA Bacterium. FDA has cleared for marketing the first rapid blood test for the drug-resistant staph bacterium known as MRSA (methicillin-resistant Staphylococcus aureus.) |
Rapid Tests for Drug-resistant TB to be Available in Developing Countries. Geneva -- People in low-resource countries who are ill with multidrug-resistant TB will get a faster diagnosis -- in two days, not the standard two to three months -- and appropriate treatment thanks to two new.. The Underlying Molecular Mechanism For Hypertension, Insulin.. Main Category: Hypertension Also Included In: Diabetes ; Biology / Biochemistry ; Immune System / Vaccines Article Date: 01 Jul 2008 - 4:00 PDT Many of the 75 million Americans with essential hypertension also.. Topanga Girl Describes Losing Sight; Motrin Blamed. Clutching a small stuffed dog, an 11-year-old Topanga Canyon girl calmly told a Malibu jury Monday that she can barely remember what it's like to see, since she was left near-blind and suffering from a painful.. Children becoming more vulnerable to diabetes. South East Asia News.Net Thursday 3rd July, 2008 The percentage of children under 14 developing Type-1 diabetes has been going up, a new study has found. Dietary Adherence Associated with Better Glucose Control in Children with Type 1 Diabetes. A study by researchers at the Joslin Diabetes Center has shown that adherence to prescribed dietary recommendations is associated with better glucose control in children with type 1 diabetes. Microsoft trumpets security additons in upcoming IE8. Microsoft Wednesday outlined new security features it will add to Internet Explorer next month, including anti-malware protection to match tools similar to those offer by its rivals and a filter the company.. Kids labelled hyperactive may be just naughty, say experts. London, July 6: Teachers are labelling children as hyperactive when they are simply naughty, psychiatrists have suggested. Gaining Body Fat May Be Good For Those With Type 1 Diabetes. Gaining body fat may be a good thing, at least for people with type 1 diabetes, say researchers at the University of Pittsburgh Graduate School of Public Health. |
|
As Population Ages And Need For Palliative Care Grows, Experts Tackle New Challenge For The First Time At European Meeting How Cephalexin care of us. Cephalexin with EU shipping Warning Required for Nonoxynol 9 Over-the-Counter Contraceptives. Over-the-counter, stand-alone vaginal contraceptive and spermicidal products containing the chemical ingredient nonoxynol 9 (N9) must now include a warning that the chemical does not protect against infection from HIV or other sexually transmitted diseases Your health in your hand. Your choice - follow advice or no. |